Medivisor, Inc. Announces Exclusive Distribution Rights in Korea for Albumax

HUNTINGTON STATION, NY--(Marketwire - October 6, 2008) - Medivisor, Inc. (PINKSHEETS: MVSR), developer of next-generation focus driven marketing tools, announced today that it has expanded its previously announced Albumax marketing agreement. Medivisor has expanded its original agreement covering US distribution and Medivisor now has the exclusive right to distribute Albumax in Korea. Albumax, a whey protein isolate formula, makes it easy for Kidney disorder patients to reach their daily requirements of high quality protein in their diet. Medivisor anticipates consummating a distribution relationship in Korea shortly.

According to The Kidney Alliance, a UK organization and sponsor of World Kidney Day, worldwide, more than 500 million people are living with some form of kidney disease; approximately one out of every ten adults has some form of kidney damage. People with chronic kidney disease are 10 times more likely than healthy individuals to die of heart attacks and strokes. South Korea's population is 49,232,844; North Korea's population is 23,479,089.

"We have recently received several inquiries regarding distribution of a number of our products in Korea," stated Dino Luzzi, CEO of Medivisor, Inc. "Medivisor is committed to expanding our existing distribution capabilities in both the United States and Korea, and broadening our customer relationships. We intend to use Korea as a starting point to launch Albumax, and other products throughout the rest of the Far East."

About Medivisor, Inc.:

Medivisor, Inc. is a developer of next-generation focus driven marketing tools, dedicated to providing technologies that offer innovative and competitive advantages to the bioscience and pharmaceutical markets. From pre-product development through product launch and commercialization, Medivisor offers worldwide experience in delivering effective and successful integrated marketing and creative communications campaigns for the benefit of its clients.

Safe Harbor

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act") Additionally, words such as "seek," "intend," "believe," "plan," "estimate," "expect," "anticipate" and other similar expressions are forward-looking statements within the meaning of the Act. Some or all of the events or results anticipated by these forward-looking statements may not occur. Further information on Medivisor risk factors is contained in its filings with the Securities and Exchange Commission. Medivisor does not undertake any duty nor does it intend to update the results of these forward-looking statements.

Contact Information: Contact: Dino Luzzi CEO Medivisor, Inc. Tel: 631.549.7100